Procter & Gamble Health Ltd.

NSE: PGHL  SECTOR: Pharmaceuticals & Drugs

4887.65
+54.4 (1.13%)

Price Summary

Today's High

₹ 4949.1

Today's Low

₹ 4817.5

52 Week High

₹ 5683

52 Week Low

₹ 2927.8

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.

Company Essentials

Market Cap

8113.19694323 Cr.

Enterprise Value

6869.77694323 Cr.

No. of Shares

1.6599382 Cr.

P/E

47.92

P/B

8.95

Face Value

₹ 10

Div. Yield

8.94%

Book Value (TTM)

₹  546.0079

CASH

1243.42 Cr.

DEBT

0 Cr.

Promoter Holding

51.82%

EPS (TTM)

₹  101.9875

Sales Growth

21.6091558878719%

ROE

73.7864931797288 %

ROCE

100.077857981763 %

Profit Growth

98.7903273301217 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1w1m3m6m1Yr3Yr5Yr

* Prices are based on daily market changes.

Valuation Chart 1w1m3m6m1Yr3Yr5Yr

* The chart is based on the standalone earnings of the company.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Sales Growth (in Cr.)

1 Year21.61%
3 Year-3.32%
5 YearNA

Profit Growth (in Cr.)

1 Year793.11%
3 Year150.18%
5 YearNA

ROE%

1 Year73.79%
3 Year33.28%
5 Year23.44%

ROCE %

1 Year100.08%
3 Year46.74%
5 Year33.42%

Debt/Equity

0

Price to Cash Flow

-62.23

Interest Cover Ratio

0

CFO/PAT (5 Yr. Avg.)

0.688325431277504

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2020 51.82 0
Dec 2019 51.82 0
Sep 2019 51.82 0
Jun 2019 51.82 0
Mar 2019 51.82 0
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 150.183584347578% for the Past 3 years.
  • Company has been maintaining healthy ROE of 33.2789630539991% over the past 3 years.
  • Company has been maintaining healthy ROCE of 46.7377010393516% over the past 3 years.
  • Company is virtually debt free.
  • Company’s PEG ratio is 0.0604253944877093.
  • The company has an efficient Cash Conversion Cycle of 48.931554994258 days.
  • Company has a healthy liquidity position with current ratio of 3.42926120893084.
  • The company has a high promoter holding of 51.82%.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 11.8815120709377.

 Limitations

  • The company has shown a poor revenue growth of -3.32030682045824% for the Past 3 years.
  • Company has negative cash flow from operations of -130.38.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020
Net Sales 233.63 225.17 236.77 228.11 201.16
Total Expenditure 179.1 175.27 187.74 169.37 148.07
Operating Profit 54.54 49.9 49.02 58.74 53.09
Other Income 17.47 6.72 6.06 10.26 10.68
Interest 0 0 0 0 0
Depreciation 4.52 4.05 4.28 4.24 8.05
Exceptional Items 0 0 0 0 0
Profit Before Tax 67.5 52.58 50.8 64.76 55.73
Tax 23.41 16.82 12.59 18.3 6.87
Profit After Tax 44.08 35.76 38.21 46.46 48.86
Adjusted EPS (Rs) 2.66 2.15 2.3 2.8 2.94

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Dec 2014 Dec 2015 Dec 2016 Dec 2017 Dec 2018
Net Sales 867.49 939.5 992.56 698.13 848.99
Total Expenditure 808.58 856.06 876.99 627.5 704.85
Operating Profit 58.91 83.44 115.57 70.63 144.14
Other Income 20.33 23.31 24.41 83.68 1007.99
Interest 0 0 0 0 0
Depreciation 12.68 23.42 24.81 19.12 21.12
Exceptional Items 0 0 0 17 6.56
Profit Before Tax 66.56 83.33 115.17 152.19 1137.57
Tax 23.34 29.77 36.04 58.28 298.85
Net Profit 43.22 53.56 79.13 93.91 838.72
Adjusted EPS (Rs.) 26.04 32.27 47.67 56.57 505.25

Balance Sheet (All Figures are in Crores.)

Particulars Dec 2014 Dec 2015 Dec 2016 Dec 2017 Dec 2018
Equity and Liabilities
Share Capital 16.6 16.6 16.6 16.6 16.6
Total Reserves 537.7 574.95 647.22 716.66 1523.51
Borrowings 0 0 0 0 0
Other N/C liabilities 390.13 395.03 398.93 430.5 491.62
Current liabilities 259.76 538.89 300.5 352.19 550.9
Total Liabilities 1204.19 1525.47 1363.25 1515.95 2582.63
Assets
Net Block 109.71 131.73 110.66 115.07 99.76
Capital WIP 27.63 7 29.98 8.9 17.35
Investments 0 0 0 0 3.82
Loans & Advances 434.13 435.76 470.5 511.59 572.52
Other N/C Assets 9.53 4.98 1.93 1.13 0
Current Assets 623.19 946 750.18 879.26 1889.18
Total Assets 1204.19 1525.47 1363.25 1515.95 2582.63
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Dec 2014 Dec 2015 Dec 2016 Dec 2017 Dec 2018
Profit Before Tax 66.56 83.33 115.18 152.19 1137.57
Adjustment 21.1 16.32 14.87 7.66 -913.68
Working Capital Changes -48.53 15.64 30.11 -46.66 -50.26
Tax Paid -34.18 -31.82 -53.12 -59.53 -304.01
Operating Cash Flow 4.95 83.47 107.04 53.66 -130.38
Investing Cash Flow 10.57 -67.84 -74.97 -47.63 1269.72
Financing Cash Flow -16.62 -11.92 -14.98 -21.98 -30.05
Net Cash Flow -1.1 3.71 17.09 -15.95 1109.29

Corporate Actions

Annual Reports

Ratings & Research Reports

Company Presentations

Company News

Procter&Gamble Healt Stock Price Analysis and Quick Research Report. Is Procter&Gamble Healt an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Procter&Gamble Healt and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs -130.38 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Procter&Gamble Healt has a Debt to Equity ratio of 0 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Procter&Gamble Healt , the EPS growth was 793.11042487488 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Procter&Gamble Healt has OPM of 16.9778207046019 % which is a good sign for profitability.
     
  • ROE: Procter&Gamble Healt have a healthy ROE of 73.7864931797288 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about Procter&Gamble Healt

X